Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-10

Clinical Trial Update: A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study [Phase 3]

View source ↗

Summary

Phase 3 trial assessing recurrence of actinic keratosis after treatment with methyl aminolevulinate hydrochloride cream versus vehicle following complete respon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methyl aminolevulinate hydrochloride cream (methyl aminolevulinate hydrochloride cream)
  • Vehicle cream (vehicle)

Snippet

Sponsor: Galderma R&D | Conditions: Keratosis, Actinic | Phase 3 | Status: TERMINATED | Results posted: 2023-10-10